BIO Europe

September 11, 2020

Participation in conferences from 26. – 29. Oktober 2020

16th Annual Meeting of the Oligo Nucleotide Therapeutics Society

Participation in conference (virtual) from 27. -30. September 2020

UGISense AG secures new financing

June 20, 2018

Dortmund, June 19, 2018 – Following the seed financing round in 2016, UGISense AG has again been able to successfully complete a funding round. In addition to all founding investors (experienced business angels in the field of biotechnology and the Lead Discovery Center Dortmund), SeedCapital II KG from Dortmund as well as the experienced business… Read more »

LDC and UGISense AG to Collaborate on New Drug Class

October 10, 2016

Dortmund, October 12, 2016 – Lead Discovery Center GmbH (LDC) and the biotech company UGISense AG are about to initiate a collaboration to jointly develop innovative drugs using the proprietary UgimeresTM antisense platform. Additionally, LDC will acquire a minority stake in UGISense AG during a first 1.2 million Euros financing round involving several private investors…. Read more »